Trademark: 97826210
Word
PRISMCORE
Status
Pending
Status Code
661
Status Date
Monday, March 11, 2024
Serial Number
97826210
Mark Type
4000
Filing Date
Tuesday, March 7, 2023

Trademark Owner History

Classifications
5 pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene and cell therapy products, namely, monoclonal antibodies, bi-specifics antibodies, chimeric antigen receptors, and synthetic receptor proteins, pharmaceuticals, and pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer
42 drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, gene and cell therapy, and oncology; providing scientific, pharmaceutical, clinical and medical research information via the internet; research and development consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; pharmaceutical, scientific, medical and clinical research and development services; drug discovery services provided through a computational platform engine used for research and development in the field of drugs

Trademark Events
Mar 11, 2024
Teas/Email Correspondence Entered
Mar 11, 2024
Correspondence Received In Law Office
Mar 11, 2024
Teas Response To Office Action Received
Dec 12, 2023
Notification Of Non-Final Action E-Mailed
Dec 12, 2023
Non-Final Action E-Mailed
Dec 12, 2023
Non-Final Action Written
Dec 5, 2023
Assigned To Examiner
Mar 27, 2023
New Application Office Supplied Data Entered
Mar 10, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24